SIRT5 and breast cancer: Nε-glutaryllysine-based compound MC3482 inhibits SIRT5 and suppresses the desuccinylation activity of SIRT5 in human breast cancer cells (MDA-MB-231) and mouse myoblasts (C2C12) without affecting its expression.